The directive emphasizes the importance of data integrity and transparency. Researchers are required to maintain detailed and accurate records of all trial activities and results. Upon completion, the results must be reported and made publicly accessible, ensuring that the scientific community and the public can benefit from the findings. This transparency is critical in advancing cancer treatments and improving patient care.
